Identification of the a kinase anchor protein 12 (AKAP12) gene as a candidate tumor suppressor of hepatocellular carcinoma
Article first published online: 3 NOV 2011
Copyright © 2011 Wiley Periodicals, Inc.
Journal of Surgical Oncology
Volume 105, Issue 4, pages 381–386, 15 March 2012
How to Cite
Hayashi, M., Nomoto, S., Kanda, M., Okamura, Y., Nishikawa, Y., Yamada, S., Fujii, T., Sugimoto, H., Takeda, S. and Kodera, Y. (2012), Identification of the a kinase anchor protein 12 (AKAP12) gene as a candidate tumor suppressor of hepatocellular carcinoma. J. Surg. Oncol., 105: 381–386. doi: 10.1002/jso.22135
- Issue published online: 6 FEB 2012
- Article first published online: 3 NOV 2011
- Manuscript Accepted: 12 OCT 2011
- Manuscript Received: 20 APR 2011
- expression array;
- single nucleotide polymorphism array;
Hepatocellular carcinoma (HCC) is a major health problem, and identification of new tumor-related genes is an urgent task.
To detect tumor-related genes effectively, we performed double-combination array analysis, which consisted of an expression array and a single nucleotide polymorphism (SNP) array of a single surgical HCC specimen.
Expression array analysis identified AKAP12 as one of the genes with reduced expression in HCC tissues when compared with non-cancerous adjacent hepatic tissues. In addition, AKAP12 expression levels in tumor tissues from 48 HCC samples were significantly lower (P < 0.001) than those in normal tissues, and the downregulation was significantly correlated with poor overall survival rate (P = 0.003). However, SNP array analysis revealed that locus 6q24-q25 where AKAP12 was located did not show chromosomal deletion. In contrast, hypermethylation in the AKAP12 promoter regions was observed in 41 of 48 HCC samples. We then confirmed that AKAP12 gene re-expression occurs after 5-aza-2′-deoxycytidine (5-aza-dC) treatment through direct sequence analysis of the AKAP12 promoter region in HCC cell lines.
The current data suggest that AKAP12 is downregulated in cancer tissues through promoter hypermethylation, and may have a role as a candidate tumor suppressor gene for HCC. J. Surg. Oncol. 2012;105:381–386. © 2011 Wiley Periodicals, Inc.